134 related articles for article (PubMed ID: 29948421)
1. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma.
Yang PW; Huang PM; Yong LS; Chang YH; Wu CW; Hua KT; Hsieh MS; Lee JM
Ann Surg Oncol; 2018 Aug; 25(8):2449-2456. PubMed ID: 29948421
[TBL] [Abstract][Full Text] [Related]
2. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
[TBL] [Abstract][Full Text] [Related]
3. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population.
Zhang P; Wang J; Lu T; Wang X; Zheng Y; Guo S; Yang Y; Wang M; Kolluri VK; Qiu L; Shen F; Fan L; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
Tumour Biol; 2015 Nov; 36(11):8789-95. PubMed ID: 26055141
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
8. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
Bulibu J; Wang W; Tang Y; Li N; Saifuding K
Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.
Yang PW; Hsieh MS; Huang YC; Hsieh CY; Chiang TH; Lee JM
PLoS One; 2014; 9(6):e100326. PubMed ID: 24945674
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
11. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
Hsieh CC; Hsu HS; Chang SC; Chen YJ
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
Umar M; Upadhyay R; Prakash G; Kumar S; Ghoshal UC; Mittal B
Mol Carcinog; 2013 Nov; 52 Suppl 1():E10-8. PubMed ID: 22692992
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
16. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
18. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 -330T>G genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Yoshino K; Nakatsu T; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2011 Jul; 18(7):1995-2002. PubMed ID: 21258967
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
